Literature DB >> 15655657

Synchronous and metachronous colorectal carcinoma.

V Papadopoulos1, A Michalopoulos, G Basdanis, K Papapolychroniadis, D Paramythiotis, P Fotiadis, P Berovalis, N Harlaftis.   

Abstract

BACKGROUND: Synchronous and metachronous colorectal carcinoma have an incidence of 2-10%. The purpose of the study was to evaluate the clinical characteristics, the accuracy of diagnostic examinations and the survival of these patients.
METHODS: From 1970 to 1999, 1160 patients with colorectal cancer were admitted to our Department. During follow-up examination 50 patients (4.3%) were found to present with multiple primary colon cancers. Fifty-two per cent were synchronous and 48% metachronous tumours.
RESULTS: The overall 5-year survival of the patients was 45.87%. Mortality was 10% for multiple primaries, while in patients with single cancer was 4.1%. The overall 5-year survival of the patients with multiple primaries tumours was 46.67%.
CONCLUSIONS: Patients with colorectal cancer must be fully studied endoscopically. There has been an improvement in survival in recent years due to better surgical techniques, the introduction of more sophisticated examination methods and the meticulous follow-up of patients at risk.

Entities:  

Mesh:

Year:  2004        PMID: 15655657     DOI: 10.1007/s10151-004-0124-y

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  21 in total

1.  Four tumours including neuroendocrine tumour of the ileum.

Authors:  Karen Waldon; Jonathan Raihan Abbas; Savana Shakir; Samir Afify
Journal:  BMJ Case Rep       Date:  2015-05-02

Review 2.  An uncommon presentation of a metachronous primary gastric tumor in a patient with a resected colorectal carcinoma: case report and review of the literature.

Authors:  Michalis Galanopoulos; Elisavet Nikolaidou; Christos Liatsos
Journal:  J Gastrointest Cancer       Date:  2015-03

3.  Clinical characteristics of colorectal cancer patients with a second primary cancer.

Authors:  Jin Woo Lee; Jong Woo Kim; Nam Keun Kim
Journal:  Ann Coloproctol       Date:  2014-02-28

4.  Metastasis of rectal carcinoma in testes and skin: case series.

Authors:  Jitendra Kumar Kushwaha; Abhinav Arun Sonkar; Nidhi Verma; Kamlesh Verma; Rajni Gupta; Anit Parihar
Journal:  Indian J Surg Oncol       Date:  2013-04-20

5.  Various clinicopathological features of patients with metachronous colorectal cancer in relation to different diagnostic intervals.

Authors:  Po-Yen Lin; Jy-Ming Chiang; Hsin-Yun Huang; Jeng-Fu You; Sum-Fu Chiang; Pao-Shiu Hsieh; Chien-Yuh Yeh; Rei-Ping Tang
Journal:  Int J Colorectal Dis       Date:  2018-06-21       Impact factor: 2.571

6.  Role of colonic stents in the management of colorectal cancers.

Authors:  Jayesh Sagar
Journal:  World J Gastrointest Endosc       Date:  2016-02-25

7.  Synchronous trifocal colorectal cancer.

Authors:  Petros Charalampoudis; Georgios C Sotiropoulos; Stylianos Kykalos; Paraskevas Stamopoulos; Gregory Kouraklis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-10

8.  Synchronous and metachronous adenocarcinomas of the large intestine.

Authors:  N Tziris; J Dokmetzioglou; K Giannoulis; I Kesisoglou; K Sapalidis; E Kotidis; O Gambros
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

9.  A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.

Authors:  Katsuhiko Nosho; Shoko Kure; Natsumi Irahara; Kaori Shima; Yoshifumi Baba; Donna Spiegelman; Jeffrey A Meyerhardt; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Gastroenterology       Date:  2009-08-14       Impact factor: 22.682

10.  Clinical characteristics of multiple primary colorectal cancers.

Authors:  Joo Won Yoon; Seung Hyun Lee; Byung Kwon Ahn; Sung Uhn Baek
Journal:  Cancer Res Treat       Date:  2008-06-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.